Sun Pharma has got the Competition Commission of India’s approval to sell the erstwhile Ranbaxy Laboratories’ two divisions in the Central nervous system (CNS) segment...
Sun Pharmaceutical Industries said that it has raised Rs 1,000 crore through issuing non-convertible debentures (NCDs) on private placement basis. It said in a BSE...
The pharma major Sun Pharma has entered into an agreement with Israel’s Weizmann Institute of Science and Spain’s Health Research Institute of Santiago de Compostela...